Literature DB >> 34540201

Enhancement of pyocyanin production by subinhibitory concentration of royal jelly in Pseudomonas aeruginosa.

Dina Auliya Amly1, Puspita Hajardhini1, Alma Linggar Jonarta2, Heribertus Dedy Kusuma Yulianto3, Heni Susilowati2.   

Abstract

Background: Pseudomonas aeruginosa, a multidrug-resistant Gram-negative bacterium, produces pyocyanin, a virulence factor associated with antibiotic tolerance. High concentrations of royal jelly have an antibacterial effect, which may potentially overcome antibacterial resistance. However, in some cases, antibiotic tolerance can occur due to prolonged stress of low-dose antibacterial agents. This study aimed to investigate the effect of subinhibitory concentrations of royal jelly on bacterial growth, pyocyanin production, and biofilm formation of P. aeruginosa.
Methods: Pseudomonas aeruginosa ATCC 10145 and clinical isolates were cultured in a royal jelly-containing medium to test the antibacterial activity. Pyocyanin production was observed by measuring the absorbance at 690 nm after 36 h culture and determined using extinction coefficient 4310 M-1 cm-1. Static microtiter plate biofilm assay performed to detect the biofilm formation, followed by scanning electron microscopy.
Results: Royal jelly effectively inhibited the viability of both strains from a concentration of 25%. The highest production of pyocyanin was observed in the subinhibitory concentration group 6.25%, which gradually decreased along with the decrease of royal jelly concentration. Results of one-way ANOVA tests differed significantly in pyocyanin production of the two strains between the royal jelly groups. Tukey HSD test showed concentrations of 12.5%, 6.25%, and 3.125% significantly increased pyocyanin production of ATCC 10145, and the concentrations of 12.5% and 6.25% significantly increased production of the clinical isolates. Concentrations of 12.5% and 6.125% significantly induced biofilm formation of P. aeruginosa ATCC 10145, in line with the results of the SEM analysis. Conclusions: The royal jelly concentration of 25% or higher inhibits bacterial growth; however, the subinhibitory concentration increases pyocyanin production and biofilm formation in P. aeruginosa . It is advisable to determine the appropriate concentration of royal jelly to obtain beneficial virulence inhibiting activity. Copyright:
© 2021 Amly DA et al.

Entities:  

Keywords:  Pseudomonas aeruginosa; antibacterial effect; pyocyanin; royal jelly

Mesh:

Substances:

Year:  2021        PMID: 34540201      PMCID: PMC8424461.4          DOI: 10.12688/f1000research.27915.4

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  39 in total

1.  Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells.

Authors:  Angelo Gismondi; Eleonora Trionfera; Lorena Canuti; Gabriele Di Marco; Antonella Canini
Journal:  Oncol Rep       Date:  2017-07-24       Impact factor: 3.906

2.  In-depth phosphoproteomic analysis of royal jelly derived from western and eastern honeybee species.

Authors:  Bin Han; Yu Fang; Mao Feng; Xiaoshan Lu; Xinmei Huo; Lifeng Meng; Bin Wu; Jianke Li
Journal:  J Proteome Res       Date:  2014-10-08       Impact factor: 4.466

3.  PQS Produced by the Pseudomonas aeruginosa Stress Response Repels Swarms Away from Bacteriophage and Antibiotics.

Authors:  Jean-Louis Bru; Brandon Rawson; Calvin Trinh; Katrine Whiteson; Nina Molin Høyland-Kroghsbo; Albert Siryaporn
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

4.  Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.

Authors:  Katsuhiro Fuse; Shigeru Fujimura; Toshiaki Kikuchi; Kazunori Gomi; Yasuhiro Iida; Toshihiro Nukiwa; Akira Watanabe
Journal:  J Infect Chemother       Date:  2012-08-03       Impact factor: 2.211

5.  Pseudomonas aeruginosa isolates from dental unit waterlines can be divided in two distinct groups, including one displaying phenotypes similar to isolates from cystic fibrosis patients.

Authors:  Myriam M Ouellet; Annie Leduc; Christine Nadeau; Jean Barbeau; Steve J Charette
Journal:  Front Microbiol       Date:  2015-01-21       Impact factor: 5.640

6.  Quantitative Analysis of Apisin, a Major Protein Unique to Royal Jelly.

Authors:  Takako Furusawa; Yasuko Arai; Kenji Kato; Kenji Ichihara
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-18       Impact factor: 2.629

7.  Universal antibiotic tolerance arising from antibiotic-triggered accumulation of pyocyanin in Pseudomonas aeruginosa.

Authors:  Kui Zhu; Shang Chen; Tatyana A Sysoeva; Lingchong You
Journal:  PLoS Biol       Date:  2019-12-16       Impact factor: 8.029

8.  MRJP1-containing glycoproteins isolated from honey, a novel antibacterial drug candidate with broad spectrum activity against multi-drug resistant clinical isolates.

Authors:  Katrina Brudzynski; Calvin Sjaarda; Robert Lannigan
Journal:  Front Microbiol       Date:  2015-07-13       Impact factor: 5.640

9.  Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance.

Authors:  Aimee L Camplin; Sarah E Maddocks
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-05-12       Impact factor: 3.944

Review 10.  Exploiting Quorum Sensing Interfering Strategies in Gram-Negative Bacteria for the Enhancement of Environmental Applications.

Authors:  Weiwei Zhang; Chenghua Li
Journal:  Front Microbiol       Date:  2016-01-08       Impact factor: 5.640

View more
  2 in total

1.  Biocompatibility and mechanical properties of an experimental E-glass fiber-reinforced composite for dentistry.

Authors:  Siti Sunarintyas; Widowati Siswomihardjo; James K H Tsoi; Jukka P Matinlinna
Journal:  Heliyon       Date:  2022-05-27

Review 2.  Royal Jelly as a Nutraceutical Natural Product with a Focus on Its Antibacterial Activity.

Authors:  Lilla Bagameri; Gabriela-Maria Baci; Daniel Severus Dezmirean
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.